American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Walt Disney
DIS
|
+$220M |
| 2 |
Elanco Animal Health
ELAN
|
+$218M |
| 3 |
Idexx Laboratories
IDXX
|
+$175M |
| 4 |
Kimberly-Clark
KMB
|
+$167M |
| 5 |
Cummins
CMI
|
+$165M |
Top Sells
| 1 |
Boeing
BA
|
+$349M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$284M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$261M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$216M |
| 5 |
UnitedHealth
UNH
|
+$216M |
Sector Composition
| 1 | Financials | 16.27% |
| 2 | Healthcare | 14.97% |
| 3 | Technology | 14.96% |
| 4 | Consumer Discretionary | 12.05% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
ACI Worldwide
ACIW
$5.18B
| $3.44M | ﹤0.01% |
+104,717
| New | +$3.44M |
|
902
Toro Company
TTC
$7.76B
| $3.38M | ﹤0.01% |
+49,164
| New | +$3.38M |
|
|
ZAGG
903
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $3.37M | ﹤0.01% |
371,458
+3,515
| +1% | +$31.9K |
|
904
Acadia Healthcare
ACHC
$2.01B
| $3.36M | ﹤0.01% |
+114,489
| New | +$3.36M |
|
905
Champion Homes, Inc.
SKY
$4.22B
| $3.34M | ﹤0.01% |
+175,920
| New | +$3.34M |
|
906
Pacira BioSciences
PCRX
$1.22B
| $3.34M | ﹤0.01% |
+87,723
| New | +$3.34M |
|
907
iShares MSCI Taiwan ETF
EWT
$6.52B
| $3.34M | ﹤0.01% |
96,459
+3,058
| +3% | +$106K |
|
|
TXNM
908
TXNM Energy, Inc.
TXNM
$5.99B
| $3.33M | ﹤0.01% |
70,289
+1,527
| +2% | +$72.3K |
|
909
Consolidated Edison
ED
$35.2B
| $3.33M | ﹤0.01% |
39,222
+36,121
| +1,165% | +$3.06M |
|
910
AudioCodes
AUDC
$289M
| $3.31M | ﹤0.01% |
+239,266
| New | +$3.31M |
|
|
NEWR
911
DELISTED
New Relic, Inc.
NEWR
| $3.26M | ﹤0.01% |
32,994
-60,091
| -65% | -$5.93M |
|
912
Best Buy
BBY
$15.9B
| $3.25M | ﹤0.01% |
45,796
-191,533
| -81% | -$13.6M |
|
913
Financial Institutions
FISI
$545M
| $3.22M | ﹤0.01% |
118,523
+1,185
| +1% | +$32.2K |
|
914
Piper Sandler
PIPR
$6.12B
| $3.21M | ﹤0.01% |
44,103
+30,955
| +235% | +$2.25M |
|
915
Heron Therapeutics
HRTX
$193M
| $3.2M | ﹤0.01% |
130,825
-3,701
| -3% | -$90.4K |
|
916
Elastic
ESTC
$9.3B
| $3.19M | ﹤0.01% |
+39,978
| New | +$3.19M |
|
917
Puma Biotechnology
PBYI
$225M
| $3.19M | ﹤0.01% |
82,166
+61,018
| +289% | +$2.37M |
|
918
Oneok
OKE
$46B
| $3.15M | ﹤0.01% |
+45,043
| New | +$3.15M |
|
|
PTLA
919
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.14M | ﹤0.01% |
+90,547
| New | +$3.14M |
|
920
Innoviva
INVA
$1.22B
| $3.14M | ﹤0.01% |
223,619
+9,869
| +5% | +$138K |
|
921
Supernus Pharmaceuticals
SUPN
$2.55B
| $3.12M | ﹤0.01% |
88,958
+7,910
| +10% | +$277K |
|
|
DNR
922
DELISTED
Denbury Resources, Inc.
DNR
| $3.08M | ﹤0.01% |
1,502,988
+32,730
| +2% | +$67.1K |
|
923
Ligand Pharmaceuticals
LGND
$3.23B
| $3.01M | ﹤0.01% |
38,385
-7,595
| -17% | -$596K |
|
|
AIMT
924
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $3M | ﹤0.01% |
134,230
-493
| -0.4% | -$11K |
|
925
Gentex
GNTX
$6.25B
| $2.95M | ﹤0.01% |
+142,641
| New | +$2.95M |
|